XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Statement of Cash Flows [Abstract]    
Net income $ 885,654 $ 601,351
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, Depletion, Amortization and Accretion 479,602 459,286
Property impairments 13,074 24,248
Non-cash (gain) loss on derivatives (331,089) 453,698
Stock/incentive-based compensation 968 29,257
Provision for deferred income taxes 100,693 94,982
Equity in net loss of affiliate 663 0
Dry hole costs 0 10,425
Net (gain) loss on sale of assets and other (186) (165)
Other, net 3,988 5,360
Changes in assets and liabilities:    
Accounts receivable 253,744 (481,812)
Inventories (19,669) (49,737)
Other current assets (3,191) (6,626)
Accounts payable trade 61,761 59,981
Revenues and royalties payable (223,212) 185,859
Accrued liabilities and other (67,713) 24,513
Current incentive compensation liability (129,362) 0
Current income taxes liability 139,063 95,957
Other noncurrent assets and liabilities (14,950) (1,960)
Net cash provided by operating activities 1,149,838 1,504,617
Cash flows from investing activities    
Exploration and development (863,989) (523,652)
Purchase of producing crude oil and natural gas properties (97,550) (441,929)
Purchase of other property and equipment (60,374) (11,069)
Proceeds from sale of assets 1,223 584
Contributions to unconsolidated affiliates 0 (64,928)
Net cash used in investing activities (1,020,690) (1,040,994)
Cash flows from financing activities    
Credit facility borrowings 1,073,000 899,000
Repayment of credit facility (1,272,000) (1,164,000)
Repayment of other debt (597) (576)
Debt issuance costs (241) (101)
Contributions from noncontrolling interests 1,872 2,778
Distributions to noncontrolling interests (11,354) (8,235)
Repurchase of common stock prior to take-private transaction 0 (99,855)
Repurchase of restricted stock for tax withholdings 0 (26,023)
Dividends paid on common stock (2,051) (83,235)
Net cash used in financing activities (211,371) (480,247)
Net change in cash and cash equivalents (82,223) (16,624)
Cash and cash equivalents at beginning of period 137,788 20,868
Cash and cash equivalents at end of period $ 55,565 $ 4,244